Sterling, MA, United States of America

Lawrence J Hayward

This inventor holds 1 USPTO granted patent. Top assignee: University of Massachusetts. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lawrence J Hayward. Retrieved from https://idiyas.com/inventor/lawrence-j-hayward

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lawrence J. Hayward and His Work on Muscle Disease Treatment.

Introduction

Lawrence J. Hayward is an inventor associated with the University of Massachusetts and based in Sterling, Massachusetts. His patent work concerns potential approaches to treating muscle disease using human skeletal muscle stem cells derived through induced pluripotent stem cell technology.

Latest Patents

Hayward is listed as an inventor on one patent: “Methods and Compositions for Treatment of Muscle Disease with iPSC-Induced Human Skeletal Muscle Stem Cells.” The invention focuses on methods and compositions involving induced pluripotent stem cell-derived human skeletal muscle stem cells for muscle disease treatment. The supplied information identifies 1 patent associated with him.

Career Highlights

Hayward’s listed patent reflects research at the intersection of stem cell technology and muscle disease. The work explores how human skeletal muscle stem cells generated from induced pluripotent stem cells may contribute to therapeutic approaches.

Collaborations

The patent lists Charles P. Emerson and Dongsheng Guo among Hayward’s coworkers. Their shared work connects the University of Massachusetts with research into stem cell-based strategies for muscle disease.

Conclusion

Lawrence J. Hayward’s patent activity highlights an effort to apply induced pluripotent stem cell technology to the development of potential treatments for muscle disease.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…